Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis-instruments for measurement and determinant factors

被引:46
作者
Lucendo, A. J. [1 ,2 ]
Arias-Gonzalez, L. [1 ,2 ]
Molina-Infante, J. [2 ,3 ]
Arias, A. [2 ,4 ]
机构
[1] Hosp Gen Tomelloso, Dept Gastroenterol, Tomelloso, Spain
[2] CIBERehd, Madrid, Spain
[3] Hosp Univ San Pedro de Alcantara, Dept Gastroenterol, Caceres, Spain
[4] Complejo Hosp La Mancha Ctr, Res Support Unit, Alcazar De San Juan, Spain
关键词
GASTROINTESTINAL DISORDERS; FOLLOW-UP; QUESTIONNAIRE; METAANALYSIS; VALIDATION; VALIDITY; DISEASE; RELIABILITY; DYSPHAGIA; FAMILIES;
D O I
10.1111/apt.14194
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Several measures have been used to assess the health-related quality of life (HRQoL) of patients with eosinophilic oesophagitis (EoE). Aims: To systematically review these HRQoL measures, to appraise measurement properties of specific instruments and to evaluate determinant factors influencing HRQoL in paediatric and adult EoE patients. Methods: We searched the PubMed, Embase, Scopus, Web of Science (WOS) and PsycINFO databases for documents providing original information on the development of measurement tools and/or evaluation of HRQoL outcomes in EoE patients of all ages. Results: Of the 596 references identified, data was collected from 34 studies (with only 16 of them being published as full papers) including a total of 1,689 individual patients. Three disease-specific HRQoL measures in EoE covering different aspects of patients' lives and developed in English, were scored positive regarding measurement properties. The PedsQL inventory (including parent and child report forms) and the Peds-QoL EoE module were the generic and specific instruments respectively used in children, while the SF-36 and EoE-QoL-A were the most used questionnaires in adults. Patients with EoE show an impaired HRQoL compared to controls, which greatly depends on symptom severity and disease duration. Severity of endoscopic features and female gender may also determine an impaired HRQoL. The effect of treatments on HRQoL requires further assessment. Conclusions: HRQoL is a relevant outcome that should be considered in clinical practice and research of EoE. Further validation studies in several languages and populations are required to support the use of disease-specific HRQoL measures.
引用
收藏
页码:401 / 409
页数:9
相关论文
共 55 条
[1]  
[Anonymous], ESOPHAGUS
[2]  
[Anonymous], 2014, REV MAN
[3]   Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies [J].
Arias, A. ;
Perez-Martinez, I. ;
Tenias, J. M. ;
Lucendo, A. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) :3-15
[4]   Efficacy of Dietary Interventions for Inducing Histologic Remission in Patients With Eosinophilic Esophagitis: A Systematic Review and Meta-analysis [J].
Arias, Angel ;
Gonzalez-Cervera, Jesus ;
Tenias, Jose M. ;
Lucendo, Alfredo J. .
GASTROENTEROLOGY, 2014, 146 (07) :1639-1648
[5]   ESOPHAGEAL EOSINOPHILIA WITH DYSPHAGIA - A DISTINCT CLINICOPATHOLOGICAL SYNDROME [J].
ATTWOOD, SEA ;
SMYRK, TC ;
DEMEESTER, TR ;
JONES, JB .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (01) :109-116
[6]  
Bajaj S, 2012, GASTROENTEROLOGY, V142, pS434
[7]  
Baraut TG, 2009, ALLERGY, V64, P474
[8]   Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions [J].
Bedell, Alyse ;
Taft, Tiffany H. ;
Keefer, Laurie ;
Pandolfi, John .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (04) :493-499
[9]   Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer [J].
Blazeby, JM ;
Alderson, D ;
Winstone, K ;
Steyn, R ;
Hammerlid, E ;
Arraras, J ;
Farndon, JR .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) :1912-1917
[10]   The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials [J].
Chang, L. ;
Lembo, A. J. ;
Lavins, B. J. ;
Shiff, S. J. ;
Hao, X. ;
Chickering, J. G. ;
Jia, X. D. ;
Currie, M. G. ;
Kurtz, C. B. ;
Johnston, J. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) :1302-1312